Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALMB-0168 in Patients With Osteosarcoma (ACE Study)
NCT04886765Phase 2Unknown
- Sponsor
- AlaMab Therapeutics
- Start
- May 2021
- Primary completion
- Nov 2023
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of ALMB-0168 in osteosarcoma (OS), sponsored by AlaMab Therapeutics. Status: unknown.
02
Drugs
ALMB-0168
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT04886765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04886765.